Fifth Third Wealth Advisors LLC Acquires 1,332 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fifth Third Wealth Advisors LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,772 shares of the healthcare conglomerate's stock after buying an additional 1,332 shares during the period. Fifth Third Wealth Advisors LLC's holdings in UnitedHealth Group were worth $7,737,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have issued reports on UNH. Barclays dropped their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday. Robert W. Baird dropped their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. HSBC reiterated a "reduce" rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, Bank of America downgraded UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $428.43.

UnitedHealth Group Trading Down 1.1%

Shares of UNH stock traded down $3.29 during mid-day trading on Tuesday, hitting $301.43. The company's stock had a trading volume of 12,622,338 shares, compared to its average volume of 6,860,855. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company's fifty day simple moving average is $426.60 and its 200-day simple moving average is $490.74. The company has a market cap of $273.44 billion, a PE ratio of 19.45, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm posted $6.91 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, CFO John F. Rex purchased 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.33% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.